Skip to content
10-Q

Quarterly Report

VICAPSYS LIFE SCIENCES, INC. VICP

0001493152-25-001743

← back to feed
Filed
Jan 10, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · Dec 13, 2024 32.37M sh
Shares Diluted Q1 2024 · Mar 31, 2024 32.07M sh
Shares Diluted Q1 2024 · Mar 31, 2023 34.59M sh
Operating Cash Flow Q1 2024 · Mar 31, 2024 −$9.42K
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$9.96K
Short Term Debt Q1 2024 · Mar 31, 2024 $12.55K
Short Term Debt Q1 2024 · Dec 31, 2023 $18.71K
Stockholders Equity Q1 2024 · Mar 31, 2024 −$2.26M
Stockholders Equity Q1 2024 · Dec 31, 2023 −$1.93M
Stockholders Equity Q1 2024 · Mar 31, 2023 −$1.14M
Stockholders Equity Q1 2024 · Dec 31, 2022 −$950.79K
Current Liabilities Q1 2024 · Mar 31, 2024 $2.26M
Current Liabilities Q1 2024 · Dec 31, 2023 $1.97M
Eps Diluted Q1 2024 · Mar 31, 2024 −$0.01
Eps Diluted Q1 2024 · Mar 31, 2023 −$0.01
Eps Basic Q1 2024 · Mar 31, 2024 −$0.01
Eps Basic Q1 2024 · Mar 31, 2023 −$0.01
Sga Expense Q1 2024 · Mar 31, 2024 $34.86K
Sga Expense Q1 2024 · Mar 31, 2023 $3.76K
Rd Expense Q1 2024 · Mar 31, 2024 $344
Rd Expense Q1 2024 · Mar 31, 2023 $10K
Net Income Q1 2024 · Mar 31, 2024 −$327.07K
Net Income Q1 2024 · Mar 31, 2023 −$211.28K
Operating Income Q1 2024 · Mar 31, 2024 −$204.26K
Operating Income Q1 2024 · Mar 31, 2023 −$211.28K
Cash And Equivalents Q1 2024 · Dec 31, 2023 $9.42K
Current Assets Q1 2024 · Dec 31, 2023 $39.66K
Total Assets Q1 2024 · Dec 31, 2023 $39.66K